Gynecologic Oncologist Joins Cancer Center at University Hospital
He began seeing
Richards specializes is treating pre-cancerous and cancerous conditions in the reproductive tract. He has more than 10 years of experience as an attending physician, providing care for patients with gynecologic cancers, which include diseases that involve the cervix, ovaries, uterus, and vulva. He also performs minimally invasive surgical procedures, including robotic surgery.
Historically, open and laparoscopic (minimally invasive) abdominal surgery has been considered the standard of care for gynecologic cancers. Although not applicable to every patient or disease process, Richards says minimally invasive surgical procedures have become appropriate in certain cases.
Robotic surgery is a method of operating inside the abdomen using robotic "arms and specialized instruments inserted through small incisions (about half an inch each) into the body. The surgeon controls the operative arms from a computer console.
"Patients who undergo robotic surgery typically experience less post-operative pain and shorter recovery times when compared to traditional open surgical methods, Richards explains. "A cancer diagnosis is stressful enough without the added frustration of a long post-surgical recovery period.
As director of womens cancer, Richards will play a key role in the joint cancer program.
The joint cancer program is a collaborative initiative involving the UC College of Medicine, Cincinnati Childrens
He says his long-term vision is to create an all-inclusive womens cancer program at Barrett Cancer Center that offers cutting edge medical therapies, clinical trials, screening programs and patient support services such as counseling, nutritional coaching, relaxation therapy and other aesthetic services.
"My goal is to transform an area that has historically been one of the most stressful places for patientsa cancer treatment centerinto a positive place where their fears are calmed and their ailments are addressed and potentially eliminated, he explains.
In addition to providing comprehensive gynecologic surgery and chemotherapy services, Richards will lead a robust clinical trials program to investigate new screening methods aimed at early disease detection and treatment strategies that may improve patient survival.
"In the past, most clinical cancer research has focused on prolonging patients lives after their diagnosisa method that yields small gains, says Richards. "Our research is beginning to focus on evaluating new treatment strategies, vaccines, genetic risk factors and other variables to identify, evaluate and treat women at risk for gynecologic cancers.
Richards joins UC from Gynecologic Oncology Associates, a successful combined private- and university-based practice in
Richards is board certified by the American Board of Obstetrics and Gynecology in both gynecologic oncology and general obstetrics/gynecology.
A
To schedule an appointment with Richards at the
For more information on gynecologic cancer clinical trials, call (513) 584-7698.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.